Compare EVO & SXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVO | SXC |
|---|---|---|
| Founded | 1993 | 1960 |
| Country | Germany | United States |
| Employees | N/A | 848 |
| Industry | Biotechnology: Pharmaceutical Preparations | Steel/Iron Ore |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 778.3M | 801.2M |
| IPO Year | 2007 | 2011 |
| Metric | EVO | SXC |
|---|---|---|
| Price | $1.82 | $10.25 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | $7.00 | ★ $9.00 |
| AVG Volume (30 Days) | 41.4K | ★ 959.0K |
| Earning Date | 04-08-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 7.17% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.10 |
| Revenue | N/A | ★ $1,600,300,000.00 |
| Revenue This Year | $1.37 | N/A |
| Revenue Next Year | $10.05 | N/A |
| P/E Ratio | ★ N/A | $102.30 |
| Revenue Growth | N/A | ★ 10.30 |
| 52 Week Low | $1.80 | $5.52 |
| 52 Week High | $4.27 | $10.68 |
| Indicator | EVO | SXC |
|---|---|---|
| Relative Strength Index (RSI) | 39.03 | 60.46 |
| Support Level | N/A | $7.64 |
| Resistance Level | $1.97 | N/A |
| Average True Range (ATR) | 0.03 | 0.34 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 17.65 | 78.00 |
Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.
SunCoke Energy Inc operates as an independent producer of coke in the Americas. Its coke is mainly used as a principal raw material in the blast furnace steelmaking process as well as in the foundry production of casted iron. The company operates through two segments: Domestic Coke and Industrial Services. It offers metallurgical and thermal coal. The company also provides handling and/or mixing services to steel, coke, electric utility, coal-producing, and other manufacturing-based customers. The majority of revenue is derived from the Domestic Coke segment.